Increasing Pain and Escalating Opioid Doses in a Patient with Cancer

Hanks GW , Portenoy RK , MacDonald N , O'Neill WN . Difficult pain problems. In: Doyle D , Hanks G , MacDonald N (eds). Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press, 1993.

Bruera E , Fainsinger R , Miller MJ , Kuehn N. The assessment of pain intensity in patients with cognitive failure: a preliminary report. J Pain Sympt Manag 1992; 7(5): 267–270.

Sjogren P , Jonsson T , Neils-Henrik J , Neils-Erick D , Jensen TS . Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain 1993; 55: 93–97.

De Conno F , Oaraceni A , Martini C , Spoldi E , Salverti M , Ventafridda V. Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine. Pain 1991; 47: 337.

Moore RD , Bone LR , Prevalence, detection and treatment of alcoholism in hospitalized patients. JAMA 1989; 261: 403–407.

Folstein MF , Folstein S , McHugh PR . Mini-mental state: a practical method for grading the cognitive state of patients. Clin J Psych 1975; (3) Res 12: 189–198.

Parkinson SK , Bailey SL , Little WL , Mueller JB . Myoclonic seizure activity with chronic high-dose spinal opioid administration. Anesthesiol 1990; 72: 743–745.

Bloom FE . Neurohumoral transmission and the central nervous system. In: Goodman-Gilman A , Rall TW , Nies AS , Taylor P (eds). The Pharmacological Basis of Therapeutics. New York: Pergamon Press, 1990; pp. 244–268.

Glare PA , Walsh TD , Pippenger CE . Normorphine, a neurotoxic metabolite? Lancet 1990; 335(8691): 725–726.

Bruera E , Pereira J. Clinical note: acute psychiatric findings in a patient receiving fentanyl for cancer pain. Pain (in press).

Sear JW , Hand CV , Moor RA , Studies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites. Br J Anaesth 1989; 2: 28–32.

Potter JM , Reid DB , Shaw RJ , Hackett P , Hickman PE . Myoclonus associated with treatment with high doses of morphine: the role of supplemental drugs. Br Med J 1989; 299: 150–153.

Jaffe JH , Martin WR . Opioid analgesics and antagonists. In: Goodman-Gilman A , Rall TW , Nies AS , Taylor P (eds). New York: Pergamon Press, 1990; pp. 1615–1639.

Payne R , Gonzales G. Pathophysiology of pain in cancer and other terminal diseases. In: Doyle D , Hanks G , MacDonald N (eds). Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press, 1993; pp. 140–147.

Galer BS , Coyle N , Pasternak GW , Portenoy RK . Individual variability in the response to different opioids: report of five cases. Pain 1992; 49: 87–91.

Fainsinger RL , Schoeller T , Bruera E. Methadone in the management of cancer pain: a review. Pain 1993; 52: 137–147.

Sjogren P , Jensen NH , Jensen TS . Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists. Pain 1994; 59:313–316.

Tong TG , Pond SM , Kreek MJ , Phenytoin-induced methadone withdrawal. Ann Intern Med 1981; 94: 349–351.

Recuenco I , Espinasa E , Garcia B , Carcas A. (Letter). Effect of dexamethasone on the decrease of serum phenytoin concentration. Ann Pharmaco Ther 1995; 29: 935.

Lawson LA , Blauin RA , Smith RB , Young AB . Phenytoin-dexamethasone interaction: a previously unreported observation. Surg Neurol 1981; 16: 23–24.

Antebi D , Bird J. The facilitation and evacation of seizures. Br J Psych 1992; 160: 155–164.

Bruera E , Franco JJ , Maltoni M , Watanabe S , Suarez-Almzaor M. Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration and opioid rotation. J Pain Sympt Manag 1995; 10(4): 298–291.

Klaassen CD . Nonmetallic environmental toxicants: air pollutants, solvents and vapors, and pesticides. In: Goodman-Gilman A , (eds). New York: Pergamon Press, 1990; pp. 1615–1639.

Curran HV , Allen D , Lader M. The effects of single doses of alpidem and lorazepam on memory and psychomotor performance in normal humans. J Psychopharmacol 1987; 2: 81–89.

Pereira J , Hanson J , Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 1997; 79(4): 835–842.

Bruera E , Pereira J , Watanabe S , Belzile M , Kuehn N , Hanson J. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone and morphine. Cancer 1996; 78(4): 852–857.

Health and Welfare Canada. Cancer Pain: A Monograph on the Management of Cancer Pain. Ottawa: Minister of Supply and Services Canada, 1984.